Study characteristics of the teenage and young adult cancer survivor study
| Patient characteristic | Respiratory death | % | Other death | % | Total |
| Overall | 1079 | 3.2 | 33 101 | 96.8 | 34 180 |
| Sex | |||||
| Male | 479 | 4.0 | 11 606 | 96.1 | 12 085 |
| Female | 600 | 2.7 | 21 495 | 97.3 | 22 095 |
| First primary neoplasm type | |||||
| Breast | 135 | 1.3 | 10 474 | 98.7 | 10 609 |
| Testicular | 98 | 4.9 | 1909 | 95.1 | 2007 |
| Cervical | 152 | 5.8 | 2490 | 94.3 | 2642 |
| Melanoma | 25 | 1.1 | 2293 | 98.9 | 2318 |
| CNS tumour | 141 | 3.4 | 3958 | 96.6 | 4099 |
| Hodgkin’s lymphoma | 134 | 4.4 | 2937 | 95.6 | 3071 |
| Non-Hodgkin’s lymphoma | 72 | 4.2 | 1647 | 95.8 | 1719 |
| Thyroid | 13 | 3.1 | 402 | 96.9 | 415 |
| Gastrointestinal | 47 | 3.4 | 1346 | 96.6 | 1393 |
| Soft tissue sarcoma | 30 | 3.4 | 863 | 96.6 | 893 |
| Ovary | 22 | 3.1 | 695 | 96.9 | 717 |
| Bladder | 30 | 5.2 | 552 | 94.9 | 582 |
| Other genitourinary | 35 | 4.1 | 819 | 95.9 | 854 |
| Head and neck | 42 | 6.1 | 648 | 93.9 | 690 |
| Leukaemia (excluding AML) | 25 | 3.3 | 743 | 96.7 | 768 |
| Other | 26 | 4.9 | 501 | 95.1 | 527 |
| Bone tumour | 11 | 3.0 | 361 | 97.0 | 372 |
| AML | 12 | 5.5 | 205 | 94.5 | 217 |
| Lung | 29 | 10.1 | 258 | 89.9 | 287 |
| Age at diagnosis (years) | |||||
| Mean | 33.2 | 33.1 | 33.1 | ||
| 15–19 | 53 | 3.8 | 1360 | 96.3 | 1413 |
| 20–24 | 83 | 3.4 | 2326 | 96.6 | 2409 |
| 25–29 | 141 | 3.0 | 4584 | 97.0 | 4725 |
| 30–34 | 257 | 2.8 | 8924 | 97.2 | 9181 |
| 35–39 | 545 | 3.3 | 15 907 | 96.7 | 16 452 |
| Treatment era | |||||
| 1971–1979 | 459 | 4.9 | 8972 | 95.1 | 9431 |
| 1980–1989 | 412 | 3.3 | 11 908 | 96.7 | 12 320 |
| 1990–1990 | 169 | 1.9 | 8811 | 98.1 | 8980 |
| 2000–2006 | 39 | 1.1 | 3410 | 98.9 | 3449 |
| Years from diagnosis | |||||
| Mean | 22.0 | 14.5 | 14.8 | ||
| 5–9 | 159 | 1.1 | 14 235 | 98.9 | 14 394 |
| 10–19 | 280 | 2.6 | 10 505 | 97.4 | 10 785 |
| 20–29 | 384 | 6.3 | 5722 | 93.7 | 6106 |
| 30–39 | 245 | 8.9 | 2500 | 91.1 | 2745 |
| 40+ | 11 | 7.3 | 139 | 92.7 | 150 |
| Attained age at exit (years) | |||||
| Mean | 55.2 | 47.7 | 47.9 | ||
| 20–29 | 20 | 1.6 | 1252 | 98.4 | 1272 |
| 30–39 | 105 | 1.8 | 5731 | 98.2 | 5836 |
| 40–49 | 229 | 1.6 | 14 420 | 98.4 | 14 649 |
| 50–59 | 317 | 4.2 | 7177 | 95.8 | 7497 |
| 60–69 | 307 | 7.7 | 3661 | 92.3 | 3968 |
| 70+ | 101 | 10.5 | 858 | 89.5 | 959 |
AML, acute myeloid leukaemia; CNS, central nervous system.